Nucleai

As we welcome Rosh Hashana, we look forward with hope for a brighter year ahead. May this new year bring healing, peace, and strength to all. Shana Tova from everyone at Nucleai. 🎗️🙏 שנה טובה ומתוקה!

We’re proud to partner with the Spatial Biology for Drug Development Summit in Boston next month. Meet us there to learn how our AI-driven spatial biomarker and diagnostics solutions are advancing next-gen therapies. Learn more: https://lnkd.in/gPX8tz5R #spatialbiology #spatialbiomarkers #drugdevelopment #diagnostics

Proud to be part of Israel’s healthtech ecosystem, breaking new ground and improving patient care with AI innovation! #healthtech #AI #biotech

We're boldly stepping into health's future at HLTH USA 2024! Meet our CEO and Co-founder, Avi Veidman to discover how Nucleai’s AI-driven spatial biomarkers and diagnostics are shaping next-gen therapies and the future of healthcare. Connect with us there! https://hubs.li/Q02QWDgX0 #BeBold #biotech #healthtech #innovation #AI #digitalpathology #AIpathology #spatialbiomarkers #diagnostics #CDx

Our recent collaboration with Dr. Arutha Kulasinghe, showcased at #WCLC24, highlights how AI-driven spatial analysis is enhancing biomarker insights, paving the way for developing predictive biomarkers for response to immunotherapy. We’re excited about the impact of this research and the future discoveries ahead! Learn more and download the full presentation! https://hubs.li/Q02QQHNF0 #spatialbiomarkers #AIpathology #DigitalPathology #PrecisionMedicine #Immunotherapy #LungCancer

As #ESMO24 wraps up, we’re excited to share insights from our latest head and neck study in collaboration with Gilead Sciences. The study reveals key differences between HPV and HPV- patients, highlighting the role of AI-powered spatial biomarkers in guiding therapy decisions. Missed our poster presentation? Download it here to explore the full findings.➡️https://lnkd.in/ghAiwg8H #ESMO2024 #SpatialBiomarkers #Biomarkers #DigitalPathology #AIPathology

Missed the presentation at #WCLC24? You can still catch up! 📄 The collaborative study, led by Dr. Arutha Kulasinghe, has uncovered a metabolic signature in tumor cells linked to immunotherapy resistance and survival in lung cancer patients. Discover how #AIPathology and #SpatialBiomarkers are driving the future of cancer care. Download the full presentation now! 🚀 👉 https://hubs.li/Q02P_f570 #WCLC2024 #LungCancer #NSCLC #biomarkers #DigitalPathology #Immunotherapy #PrecisionMedicine Ettai Markovits

Wrapping up another great day at ESMO - European Society for Medical Oncology Congress! Ettai Markovits, Ken Bloom, and Abhishek Aggarwal from Gilead Sciences were on hand to discuss the latest results from our head and neck study, revealing key spatial differences between HPV and HPV- patients that could serve as predictive biomarkers for therapy. Did you catch our poster? Meet us to learn more! https://hubs.li/Q02PVrnM0 #ESMO24 #SpatialBiomarkers #AIPathology #DigitalPathology #biomarkers #PrecisionMedicine

The Nucleai team is heading to Barcelona this weekend for the ESMO - European Society for Medical Oncology Congress. Meet our Head of Pathology, Ken Bloom, and Director of Biomedical Research, Ettai Markovits, to explore how AI spatial biomarkers and diagnostics are powering next-gen therapies. Book a meeting here ➡️https://hubs.li/Q02PHkjv0 And be sure to join us for our poster session on Saturday, Sept 14, where we’ll be presenting our latest findings in collaboration with Gilead Sciences. 📍 Poster #916P - Deep spatial profiling of head and neck squamous cell carcinoma offers insights into the tumor microenvironment of hpv-stratified patients #ESMO #SpatialBiomarkers #AIPathology #biomarker #DigitalPathology #ESMO24

We are excited to share the latest findings from our head and neck study in collaboration with Gilead Sciences at ESMO - European Society for Medical Oncology Congress 2024. Our research reveals distinct tumor microenvironment patterns in HPV and HPV- patients, offering potential insights for future therapeutic approaches. Stop by our poster "Deep spatial profiling of head and neck squamous cell carcinoma offers insights into the tumor microenvironment of HPV-stratified patients" on Saturday, Sept 14 to meet our Head of Pathology, Ken Bloom and our Director of Biomedical Research, Ettai Markovits to learn how deep spatial profiling can offer actionable insights that may guide diagnostic and therapeutic decisions. View the abstract here 👇 https://hubs.li/Q02PtXy00 #ESMO24 #ESMO #SpatialBiomarker #biomarker #Immunotherapy #PrecisionMedicine #DigitalPathology